IP Library Granted Patent US 9,937,099
Granted Patent B2
US 9,937,099 · App. 14/751,435 · Granted Apr 10, 2018

Trilayer coated pharmaceutical packaging with low oxygen transmission rate

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,937,099
App. No.
14/751,435
Granted
Apr 10, 2018
Kind
B2
Abstract

An article is described including an article surface and a coating set comprising an optional tie coating or layer, a barrier coating or layer, and a pH protective layer. The respective coatings or layers can be applied by chemical vapor deposition of a polysiloxane or polysilazane precursor in the presence of oxygen. Examples of such an article are a prefilled thermoplastic syringe or thermoplastic pharmaceutical vial with a coated interior portion containing a pharmaceutical preparation or other fluid with a pH of 4 to 8, alternatively 5 to 9. The barrier coating or layer prevents oxygen from penetrating into the thermoplastic syringe or vial. The tie coating or layer, if present, and the pH protective coating or layer protect the barrier layer from the contents of the syringe or vial.

Claims (38)

1. A vessel comprising:

a thermoplastic wall:

defining a lumen,

having an interior surface facing the lumen, and

having a first oxygen transmission rate respecting ingress of oxygen;

a coating set on the interior surface, comprising:

a tie coating or layer having an interior surface facing the lumen and an outer surface facing the wall interior surface;

a barrier coating or layer having an outer surface facing the wall interior surface and, if present, the interior surface of the tie coating or layer;

and a pH protective coating or layer having an interior surface facing the lumen and an outer surface facing the interior surface of the barrier coating or layer;

in which the barrier coating or layer is effective to provide a second oxygen transmission rate lower than the first oxygen transmission rate;

in which the coating set on the interior surface is effective to maintain the second oxygen transmission rate lower than the first oxygen transmission rate for at least six months of contact between a fluid in the lumen having a pH from 3 to 9 and the pH protective coating or layer.

2. A vessel comprising:

a thermoplastic wall:

defining a lumen,

having an interior surface facing the lumen, and

having a first oxygen transmission rate respecting ingress of oxygen;

a coating set on the interior surface, comprising:

optionally, a tie coating or layer having an interior surface facing the lumen and an outer surface facing the wall interior surface;

a barrier coating or layer having an outer surface facing the wall interior surface and the interior surface of the tie coating or layer;

and a pH protective coating or layer having an interior surface facing the lumen and an outer surface facing the interior surface of the barrier coating or layer, in which the pH protective coating or layer comprises SiO x C y , wherein x is from about 0.5 to about 2.4 and y is from about 0.6 to about 3;

in which the barrier coating or layer is effective to provide a second oxygen transmission rate lower than the first oxygen transmission rate;

a fluid having a pH from 3 to 9 contained in the lumen; and

a closure closing the vessel to provide a closed pharmaceutical package;

in which the coating set on the interior surface is effective to maintain the second oxygen transmission rate lower than the first oxygen transmission rate for at least six months of contact between the fluid in the lumen and the pH protective coating or layer.

3. The vessel of claim 2 , in which the thermoplastic wall comprises a polyester, polyethylene terephthalate (PET), polyethylene naphthalate (PEN); a polyolefin, cyclic olefin polymer (COP), cyclic olefin copolymer (COC), polypropylene (PP), or a polycarbonate.

4. The vessel of claim 2 , in which the vessel comprises a sample collection tube, a syringe barrel, a vial, a blister package, an ampoule, a cartridge, an injection pen, a bottle, a pouch, a pump, a sprayer, a stopper, a needle, a plunger, a cap, a stent, a catheter, an implant, a plastic-coated vial, a plastic coated syringe, a plastic coated ampoule, a plastic coated bottle, or any other type of container or conduit for a fluid.

5. The vessel of claim 2 , comprising the tie coating or layer, in which the tie coating or layer is between 5 and 50 nm thick.

6. The vessel of claim 2 , in which the barrier coating or layer is from 2 to 1000 nm thick.

7. The vessel of claim 2 , in which the pH protective coating or layer as applied is between 10 and 1000 nm thick.

8. The vessel of claim 2 , comprising the tie coating or layer, in which the tie coating or layer comprises SiO x C y wherein x is from about 0.5 to about 2.4 and y is from about 0.6 to about 3.

9. The vessel of claim 2 , in which the barrier coating or layer comprises SiO x , wherein x is from 1.5 to 2.9.

10. The vessel of claim 2 , comprising the tie coating or layer, in which the tie coating or layer is applied by PECVD.

11. The vessel of claim 2 , in which the barrier coating or layer is applied by PECVD.

12. The vessel of claim 2 , in which the pH protective coating or layer is applied by PECVD.

13. The vessel of claim 2 , in which the fluid has a pH between 5 and 9.

14. The vessel of claim 2 , in which the fluid composition is an aqueous liquid.

15. The vessel of claim 2 , in which the calculated shelf life of the vessel (total Si/Si dissolution rate) is more than six months.

16. The vessel of claim 2 , in which the fluid contained in the lumen has a pH between 5 and 9; wherein the calculated shelf life of the package is more than six months at a storage temperature of 4° C.

Assignments (7)
SECURITY INTEREST Recorded Sep 5, 2024
From: SIO2 MEDICAL PRODUCTS, LLC
To: OAKTREE FUND ADMINISTRATION, LLC
Reel/Frame 068849/0489 →
CHANGE OF NAME Recorded Sep 4, 2024
From: SIO2 MEDICAL PRODUCTS, INC.
To: SIO2 MEDICAL PRODUCTS, LLC
Reel/Frame 068839/0691 →
SECURITY INTEREST Recorded Aug 9, 2023
From: SIO2 MEDICAL PRODUCTS, INC.
To: OAKTREE FUND ADMINISTRATION, LLC
Reel/Frame 064544/0940 →
RELEASE OF SECURITY INTEREST Recorded Apr 5, 2023
From: THE TEACHERS RETIREMENT SYSTEM OF ALABAMA
To: SIO2 MEDICAL PRODUCTS, INC.
Reel/Frame 063257/0371 →
SECURITY INTEREST Recorded Dec 7, 2022
From: SIO2 MEDICAL PRODUCTS, INC.
To: SALZUFER HOLDING INC., AS ADMINISTRATIVE AGENT
Reel/Frame 062094/0121 →
SECURITY INTEREST Recorded Dec 21, 2021
From: SIO2 MEDICAL PRODUCTS, INC.
To: OAKTREE FUND ADMINISTRATION, LLC
Reel/Frame 058562/0158 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 20, 2016
From: WEIKART, CHRISTOPHER; CLARK, BECKY L.; STEVENSON, ADAM; FELTS, JOHN T.
To: SIO2 MEDICAL PRODUCTS, INC.
Reel/Frame 038956/0671 →